AstraZeneca and Lilly to collaborate on clinical trials with ZD-1839 and gemcitabine combination Dec. 28, 2001
TAS-108 well tolerated and readily absorbed after oral dosing in preliminary clinical trial Dec. 27, 2001
RSS